View Item 

Show simple item record

Eplerenone prevents an increase in serum carboxy‐terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure

dc.contributor.authorStienen, Susan
dc.contributor.authorFerreira, Jo�o Pedro
dc.contributor.authorPitt, Bertram
dc.contributor.authorCleland, John G.
dc.contributor.authorPellicori, Pierpaolo
dc.contributor.authorGirerd, Nicolas
dc.contributor.authorRossignol, Patrick
dc.contributor.authorZannad, Faiez
dc.date.accessioned2020-06-03T15:22:26Z
dc.date.availableWITHHELD_12_MONTHS
dc.date.available2020-06-03T15:22:26Z
dc.date.issued2020-05
dc.identifier.citationStienen, Susan; Ferreira, Jo�o Pedro ; Pitt, Bertram; Cleland, John G.; Pellicori, Pierpaolo; Girerd, Nicolas; Rossignol, Patrick; Zannad, Faiez (2020). "Eplerenone prevents an increase in serum carboxy‐terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure." European Journal of Heart Failure 22(5): 901-903.
dc.identifier.issn1388-9842
dc.identifier.issn1879-0844
dc.identifier.urihttps://hdl.handle.net/2027.42/155465
dc.publisherJohn Wiley & Sons, Ltd.
dc.titleEplerenone prevents an increase in serum carboxy‐terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelCardiovascular Medicine
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/155465/1/ejhf1812.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/155465/2/ejhf1812_am.pdf
dc.identifier.doi10.1002/ejhf.1812
dc.identifier.sourceEuropean Journal of Heart Failure
dc.identifier.citedreferenceIraqi W, Rossignol P, Angioi M, Fay R, Nuee J, Ketelslegers JM, Vincent J, Pitt B, Zannad F. Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post‐Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study. Circulation 2009; 119: 2471 – 2479.
dc.identifier.citedreferenceLomeo A, Bolner A. Stability of several biochemical markers of bone metabolism. Clin Chem 2000; 46: 1200 – 1202.
dc.identifier.citedreferenceQuerejeta R, López B, González A, Sánchez E, Larman M, Martínez Ubago JL, Díez J. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 2004; 110: 1263 – 1268.
dc.identifier.citedreferenceLopez B, Gonzalez A, Ravassa S, Beaumont J, Moreno MU, San Jose G, Querejeta R, Díez J. Circulating biomarkers of myocardial fibrosis: the need for a reappraisal. J Am Coll Cardiol 2015; 65: 2449 – 2456.
dc.identifier.citedreferencePitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M; Eplerenone Post‐Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309 – 1321.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ejhf1812.pdf
Size:
194.8KB
Format:
PDF
View/Open
Name:
ejhf1812_am.pdf
Size:
235.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.